Price Alert

Bioventus Inc. (BVS)

NASDAQ: BVS · Real-Time Price · USD

7.02

0.31 (4.62%)

At close: Oct 03, 2025, 3:59 PM

6.99

-0.43%

After-hours: Oct 03, 2025, 07:55 PM EDT

4.62% (1D)

Bid	6.61
Market Cap	469.58M
Revenue (ttm)	564.14M
Net Income (ttm)	-158K
EPS (ttm)	0.03
PE Ratio (ttm)	234
Forward PE	8.95
Analyst	Buy
Dividends	n/a

Ask	7.2
Volume	243,467
Avg. Volume (20D)	422,300
Open	6.74
Previous Close	6.71
Day's Range	6.74 - 7.14
52-Week Range	5.81 - 14.38
Beta	0.81
Ex-Dividend Date	n/a

About BVS

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol BVS

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for BVS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Bioventus Inc. is scheduled to release its earnings on Nov 4, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

+18.73%

Bioventus shares are trading higher after the comp... Unlock content with Pro Subscription

5 months ago

-11.81%

Bioventus shares are trading lower following Q1 reported financial results.

News

3 weeks ago · seekingalpha.com

Bioventus Inc. (BVS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Bioventus Inc. (NASDAQ:BVS ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 1:05 PM EDT Company Participants Mark Singleton - Senior VP & CFO Presentation Unknown Analyst T...

1 month ago · seekingalpha.com

Bioventus Inc. (BVS) Q2 2025 Earnings Call Transcript

Bioventus Inc. (NASDAQ:BVS ) Q2 2025 Earnings Conference Call August 6, 2025 8:30 AM ET Company Participants David Crawford - Vice President of Investor Relations & Treasurer Mark L. Singleton - Senio...

2 months ago · zacks.com

Bioventus (BVS) Misses Q2 Earnings and Revenue Estimates

Bioventus (BVS) came out with quarterly earnings of $0.21 per share, missing the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.19 per share a year ago.